# Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)

> **NCT00135707** · PHASE3 · COMPLETED · sponsor: **The George Washington University Biostatistics Center** · enrollment: 10154 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Dietary Supplement/Vitamins
- **DRUG:** Placebo for Vitamin C and Vitamin E

## Key facts

- **NCT ID:** NCT00135707
- **Lead sponsor:** The George Washington University Biostatistics Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2008-10
- **Final completion:** 2009-01
- **Target enrollment:** 10154 (ACTUAL)
- **Last updated:** 2019-02-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135707, "Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00135707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*